Trailing-twelve-month (TTM) revenue is $703.99 Million with a year-over-year growth of +10.51%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $169,882,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-31 | $175,282,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-20 |
| Q1 FY2026Period ended 2026-03-31 | $176,648,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q2 FY2026Period ended 2026-06-30 | $182,175,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $703,987,000 |
Current P/S: $6,807,798,270 market capitalization ÷ $703,987,000 TTM revenue = 9.67x.
Market capitalization source: FMP quote. Quote observed 2026-10-02T19:55:07.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $182.18M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-02T19:55:49.395Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-01.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20182018-12-31 · USD | FY20192019-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|
| Reportable Segment | N/A | N/A | $608M | $669M |
| Subscription Revenue | $141M | $161M | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Foreign | $133M | N/A | N/A | N/A | N/A | N/A |
| Non-US | N/A | $160M |
$703.99M
$703.99 Million
+10.51%
vs. $637.03M a year ago (TTM)
+12.87%
5 Year compound annual growth rate
1 Year
+10.51%
3 Year
+10.32%
5 Year
+12.87%
10 Year
+14.51%
15 Year
+16.76%
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $669.13M | +$61.55M | +10.13% |
| 2024 | $607.57M | +$53.11M | +9.58% |
| 2023 | $554.46M | +$64.73M | +13.22% |
| 2022 | $489.72M | +$78.55M | +19.10% |
| 2021 | $411.17M | +$48.21M | +13.28% |
| 2020 |
TTM Growth
+10.51%
3-Year CAGR
+10.32%
5-Year CAGR
+12.87%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-02T19:55:49.395Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-01.
| $222M |
| $253M |
| $292M |
| UNITED STATES | $230M | $251M | $292M | $332M | $355M | $377M |
|---|
| $362.96M |
| +$41.36M |
| +12.86% |
| 2019 | $321.61M | +$42.72M | +15.32% |
| 2018 | $278.89M | +$48.06M | +20.82% |
| 2017 | $230.83M | +$32.90M | +16.62% |
| 2016 | $197.93M | +$33.64M | +20.48% |
